MEDICOX (054180) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, MEDICOX (054180) reported revenue of 28.2 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202528.2 billion KRW-5.7 billion KRW-11.9 billion KRW[source]
202430.6 billion KRW-10.0 billion KRW-21.4 billion KRW[source]
202326.9 billion KRW-10.7 billion KRW-34.4 billion KRW[source]
202221.8 billion KRW-12.3 billion KRW-42.6 billion KRW[source]
202117.4 billion KRW-9.3 billion KRW-23.9 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202568.3 billion KRW20.9 billion KRW47.4 billion KRW[source]
202481.3 billion KRW28.6 billion KRW52.7 billion KRW[source]
202396.5 billion KRW34.1 billion KRW62.3 billion KRW[source]
2022107.4 billion KRW43.8 billion KRW63.6 billion KRW[source]
2021102.0 billion KRW35.8 billion KRW66.2 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
2025-3.4 billion KRW6.0 billion KRW-3.4 billion KRW[source]
2024-6.6 billion KRW1.5 billion KRW4.6 billion KRW[source]
2023-8.9 billion KRW-10.3 billion KRW18.1 billion KRW[source]
2022-9.2 billion KRW-15.5 billion KRW23.4 billion KRW[source]
2021-7.2 billion KRW-24.0 billion KRW32.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice